253 related articles for article (PubMed ID: 21068007)
21. A reference map of sphingolipids in murine tissues.
Muralidharan S; Shimobayashi M; Ji S; Burla B; Hall MN; Wenk MR; Torta F
Cell Rep; 2021 Jun; 35(11):109250. PubMed ID: 34133933
[TBL] [Abstract][Full Text] [Related]
22. Bioactive sphingolipid profile in a xenograft mouse model of head and neck squamous cell carcinoma.
Bai A; Liu X; Bielawski J; Hannun YA
PLoS One; 2019; 14(4):e0215770. PubMed ID: 31002723
[TBL] [Abstract][Full Text] [Related]
23. Myriocin treatment affects lipid metabolism in skeletal muscles of rats with streptozotocin-induced type 1 diabetes.
Kurek K; Garbowska M; Ziembicka DM; Łukaszuk B; Rogowski J; Chabowski A; Górski J; Żendzian-Piotrowska M
Adv Med Sci; 2017 Mar; 62(1):65-73. PubMed ID: 28189121
[TBL] [Abstract][Full Text] [Related]
24. Diabetes alters sphingolipid metabolism in the retina: a potential mechanism of cell death in diabetic retinopathy.
Fox TE; Han X; Kelly S; Merrill AH; Martin RE; Anderson RE; Gardner TW; Kester M
Diabetes; 2006 Dec; 55(12):3573-80. PubMed ID: 17130506
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of ceramide and sphingosine 1-phosphate on ERM phosphorylation: probing sphingolipid signaling at the outer plasma membrane.
Canals D; Jenkins RW; Roddy P; Hernández-Corbacho MJ; Obeid LM; Hannun YA
J Biol Chem; 2010 Oct; 285(42):32476-85. PubMed ID: 20679347
[TBL] [Abstract][Full Text] [Related]
26. High-cholesterol diet augments endothelial dysfunction via elevated oxidative stress and reduced tetrahydrobiopterin in Ins2(Akita) mice, an autosomal dominant mutant type 1 diabetic model.
Yang XQ; Chen AF
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):764-9. PubMed ID: 19207718
[TBL] [Abstract][Full Text] [Related]
27. Principles of bioactive lipid signalling: lessons from sphingolipids.
Hannun YA; Obeid LM
Nat Rev Mol Cell Biol; 2008 Feb; 9(2):139-50. PubMed ID: 18216770
[TBL] [Abstract][Full Text] [Related]
28. Role of bioactive sphingolipids in physiology and pathology.
Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
[TBL] [Abstract][Full Text] [Related]
29. High levels of sphingolipids in human breast cancer.
Nagahashi M; Tsuchida J; Moro K; Hasegawa M; Tatsuda K; Woelfel IA; Takabe K; Wakai T
J Surg Res; 2016 Aug; 204(2):435-444. PubMed ID: 27565080
[TBL] [Abstract][Full Text] [Related]
30. [Recent advances in study of sphingolipids on liver diseases].
Wang SY; Zhang JL; Zhang D; Bao XQ; Sun H
Yao Xue Xue Bao; 2015 Dec; 50(12):1551-8. PubMed ID: 27169276
[TBL] [Abstract][Full Text] [Related]
31. Sphingolipids in neurodegeneration (with focus on ceramide and S1P).
Wang G; Bieberich E
Adv Biol Regul; 2018 Dec; 70():51-64. PubMed ID: 30287225
[TBL] [Abstract][Full Text] [Related]
32. Plasma cross-gestational sphingolipidomic analyses reveal potential first trimester biomarkers of preeclampsia.
Dobierzewska A; Soman S; Illanes SE; Morris AJ
PLoS One; 2017; 12(4):e0175118. PubMed ID: 28384202
[TBL] [Abstract][Full Text] [Related]
33. Cancer treatment strategies targeting sphingolipid metabolism.
Oskouian B; Saba JD
Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
[TBL] [Abstract][Full Text] [Related]
34. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
[TBL] [Abstract][Full Text] [Related]
35. Sphingolipids in inflammation: pathological implications and potential therapeutic targets.
Nixon GF
Br J Pharmacol; 2009 Oct; 158(4):982-93. PubMed ID: 19563535
[TBL] [Abstract][Full Text] [Related]
36. Bimodal effect of advanced glycation end products on mesangial cell proliferation is mediated by neutral ceramidase regulation and endogenous sphingolipids.
Geoffroy K; Wiernsperger N; Lagarde M; El Bawab S
J Biol Chem; 2004 Aug; 279(33):34343-52. PubMed ID: 15184394
[TBL] [Abstract][Full Text] [Related]
37. Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet.
Brozinick JT; Hawkins E; Hoang Bui H; Kuo MS; Tan B; Kievit P; Grove K
Int J Obes (Lond); 2013 Aug; 37(8):1064-70. PubMed ID: 23207405
[TBL] [Abstract][Full Text] [Related]
38. Novel Insights into the Role of HDL-Associated Sphingosine-1-Phosphate in Cardiometabolic Diseases.
Diarte-Añazco EMG; Méndez-Lara KA; Pérez A; Alonso N; Blanco-Vaca F; Julve J
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842389
[TBL] [Abstract][Full Text] [Related]
39. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.
Laviad EL; Albee L; Pankova-Kholmyansky I; Epstein S; Park H; Merrill AH; Futerman AH
J Biol Chem; 2008 Feb; 283(9):5677-84. PubMed ID: 18165233
[TBL] [Abstract][Full Text] [Related]
40. Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans.
Bergman BC; Brozinick JT; Strauss A; Bacon S; Kerege A; Bui HH; Sanders P; Siddall P; Kuo MS; Perreault L
Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E398-408. PubMed ID: 26126684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
